Glucosio Monico

Glucosio Monico is a sterile aqueous solution for injection that contains glucose monohydrate as the active ingredient. The product is supplied in a concentration that provides a defined amount of glucose per milliliter, though the exact strength is not specified in the label. It is marketed in the European Union and is available by prescription for parenteral administration and can be administered intravenously or intramuscularly under clinical supervision.

Glucosio Monico is indicated for situations where rapid glucose supplementation is required.

- Treatment of documented hypoglycemia in patients unable to take oral carbohydrates. - Provision of caloric support as part of parenteral nutrition regimens. - Replacement of fluid and electrolytes in conjunction with glucose delivery. - Support during peri‑operative fasting when oral intake is suspended. - Management of glucose deficits in critical‑care settings such as trauma or sepsis. - Adjunctive therapy for patients receiving insulin infusion to prevent hypoglycemia.

Glucosio Monico may be associated with a range of adverse reactions, most of which are mild and transient.

Common: - Local irritation or pain at the injection site. - Mild hyperglycemia with transient elevation of blood glucose. - Nausea or vomiting related to rapid glucose infusion. - Electrolyte shifts such as mild hypokalemia. - Headache due to rapid osmotic changes. - Transient increase in serum osmolality causing mild thirst.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reactions including rash, urticaria, or anaphylaxis. - Volume overload resulting in pulmonary edema. - Metabolic acidosis in patients with impaired renal function.

When prescribing Glucosio Monico, clinicians should consider several precautionary measures to ensure safe use.

- Assess baseline blood glucose and adjust dosage to avoid hyperglycemia. - Monitor electrolyte levels, especially potassium and sodium, during therapy. - Use caution in patients with renal insufficiency or congestive heart failure. - Avoid rapid infusion rates that may cause circulatory overload. - Evaluate for a history of hypersensitivity to glucose solutions. - Consider pregnancy status; data on fetal safety are limited. - Ensure aseptic technique to prevent contamination of the sterile solution.

Glucosio Monico can interact with other medications or clinical conditions, requiring attention to timing and dosing.

Avoid: - Concurrent use of high‑dose insulin without glucose monitoring, which may precipitate severe hypoglycemia. - Administration with other hypertonic glucose solutions, increasing risk of hyperosmolar complications. - Concurrent use with sodium bicarbonate solutions may exacerbate metabolic alkalosis. - Mixing with other intravenous medications in the same line can cause precipitation.

Use with caution: - Co‑administration with potassium‑sparing diuretics; monitor serum potassium closely. - Use in patients receiving catecholamines or glucocorticoids, as these agents can raise blood glucose further. - Combination with fluid resuscitation protocols; adjust infusion rates to prevent volume overload. - When combined with parenteral lipid emulsions, monitor triglyceride levels.